Fresenius Medical Care Meadows Field is a medicare approved dialysis facility center in Bakersfield, California and it has 21 dialysis stations. It is located in Kern county at 3101 Pegasus Drive, Suite 100, Bakersfield, CA, 93308. You can reach out to the office of Fresenius Medical Care Meadows Field at (661) 615-4200. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fresenius Medical Care Meadows Field has the following ownership type - Profit. It was first certified by medicare in April, 2009. The medicare id for this facility is 552623 and it accepts patients under medicare ESRD program.
| Name | Fresenius Medical Care Meadows Field |
|---|---|
| Location | 3101 Pegasus Drive, Suite 100, Bakersfield, California |
| No. of Dialysis Stations | 21 |
| Medicare ID | 552623 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 3101 Pegasus Drive, Suite 100, Bakersfield, California, 93308 | |
| (661) 615-4200 | |
| NPI Number | 1386828010 |
| Match | Possible same name, address or phone number |
| Organization Name | Pegasus Dialysis, LLC |
| Address | 3101 Pegasus Dr Ste 100, Bakersfield, California 93308 |
| Phone Number | (661) 615-4200 |
| NPI Number | 1497111967 |
| Match | Possible same name, address or phone number |
| Organization Name | Fresenius Medical Care Pegasus, LLC |
| Doing Business As | Fresenius Medical Care Meadows Field |
| Address | 3101 Pegasus Dr Ste 100, Bakersfield, California 93308 |
| Phone Number | (661) 615-4200 |
| Dialysis patients with Hemoglobin data | 30 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 30 |
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
| Adult patients getting regular hemodialysis at the center | 62 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 536 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 98 |
| Adult patients getting regular peritoneal dialysis at the center | 24 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 161 |
| Percentage of adult peritoneal dialysis patients with Kt/V greater than or equal to 1.7 | 98 |
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fresenius Medical Care Meadows Field with elevated calcium levels.
| Patients in the hypercalcemia summary | 82 |
| Hypercalcemia patient months | 703 |
| Percentage of adult patients with serum calcium greater than 10.2 mg/dL | 1 |
| Patients in the serum phosphorus summary | 88 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 5 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 22 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 24 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 28 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 20 |
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 64 |
| Patient months included in arteriovenous fistula and catheter summaries | 565 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 72 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 14 |
The rate of hospitalization shows you whether patients who were being treated regularly at Fresenius Medical Care Meadows Field were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 71 |
| Hospitalization Rate in facility | 133.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 229.5 |
| Hospitalization Rate: Lower Confidence Limit | 82.2 |
The rate of readmission shows you whether patients who were being treated regularly at Fresenius Medical Care Meadows Field were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 32.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 50.8 |
| Readmission Rate: Lower Confidence Limit | 17.8 |
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fresenius Medical Care Meadows Field's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 45 |
| Transfusion Rate in facility | 27.8 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 78.4 |
| Transfusion Rate: Lower Confidence Limit | 12.7 |
The rate of mortality shows you whether patients who were being treated regularly at Fresenius Medical Care Meadows Field lived longer than expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 266 |
| Mortality Rate in facility | 21.8 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 34.7 |
| Mortality Rate: Lower Confidence Limit | 14.1 |
Central Bakersfield Dialysis Center Location: 5101 White Ln, Suite A, Bakersfield, California, 93309 Phone: (661) 398-2251 |
Davita Bakersfield Brimhall Dialysis Location: 8501 Brimhall Road, Bldg. 500, Bakersfield, California, 93312 Phone: (661) 387-6603 |
Davita Bakersfield Oak St Dialysis Location: 422 Oak Street, Bakersfield, California, 93304 Phone: (661) 631-0227 |
Davita Casa Del Rio Home Training Location: 8331 Brimhall Road Building 900, Suite 902, Bakersfield, California, 93312 Phone: (661) 387-6405 |
Davita Northeast Dialysis Location: 3501 Mall View Rd, Bakersfield, California, 93306 Phone: (661) 872-3580 |